NGENF (NervGen Pharma) 3-Year Book Growth Rate : 0.00% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma 3-Year Book Growth Rate?

NervGen Pharma's Book Value per Share for the quarter that ended in Sep. 2024 was $0.10.

During the past 12 months, NervGen Pharma's average Book Value per Share Growth Rate was 52.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of NervGen Pharma was 58.20% per year. The lowest was 4.80% per year. And the median was 31.50% per year.

Competitive Comparison of NervGen Pharma's 3-Year Book Growth Rate

For the Biotechnology subindustry, NervGen Pharma's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NervGen Pharma's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NervGen Pharma's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where NervGen Pharma's 3-Year Book Growth Rate falls into.

NervGen Pharma 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

NervGen Pharma (OTCPK:NGENF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

NervGen Pharma 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

NervGen Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

9UA:Germany NGEN:Canada

Address

112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4

Website

https://www.nervgen.com

NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.

NervGen Pharma Headlines

From GuruFocus

NervGen Pharma To Webcast At VirtualInvestorConferences.com July 11th

By PRNewswire PRNewswire • 07-09-2019